停用抗凝后复发性静脉血栓栓塞症在口服复方避孕药相关静脉血栓栓塞症女性中的系统评价与荟萃分析
该系统评价与荟萃分析纳入19项研究,比较口服复方避孕药(COC)相关静脉血栓栓塞症(VTE)女性与无诱因VTE女性停用抗凝后的复发率。COC相关VTE组复发率为1.22/100人年(95%CI 0.92-1.62,I²=6%),无诱因VTE组为3.89/100人年(95%CI 2.93-5.17,I²=74%),未经调整的发病率比为0.34(95%CI 0.26-0.46,I²=3%)。COC相关VTE女性停用抗凝后复发风险较低,且低于无诱因VTE女性。
要点
- COC相关VTE女性停用抗凝后VTE复发率为1.22/100人年(95%CI 0.92-1.62)。
- 无诱因VTE女性停用抗凝后VTE复发率为3.89/100人年(95%CI 2.93-5.17)。
- 两组未经调整的发病率比为0.34(95%CI 0.26-0.46),COC相关VTE组复发风险低于无诱因VTE组。
核心结论
- COC相关VTE女性停用抗凝后复发风险较低,且低于无诱因VTE女性。
研究设计与样本
- 系统评价与荟萃分析,检索Cochrane对照试验中心注册库、Cochrane系统评价数据库、Embase Classic+Embase及Medline ALL至2020年7月,并检索纳入研究的引文。
- 纳入随机对照试验、前瞻性队列研究及上述研究类型的荟萃分析,采用随机效应模型分析。
- 共纳入19项研究,包括1537例COC相关VTE女性(5828人年)和1974例无诱因VTE女性(7798人年),研究偏倚风险低。
主要发现
- COC相关VTE组VTE复发率为1.22/100人年(95%CI 0.92-1.62,I²=6%)。
- 无诱因VTE组VTE复发率为3.89/100人年(95%CI 2.93-5.17,I²=74%)。
- 两组未经调整的发病率比为0.34(95%CI 0.26-0.46,I²=3%)。
关键数值与推荐
- COC相关VTE组复发率1.22/100人年(95%CI 0.92-1.62,I²=6%)。
- 无诱因VTE组复发率3.89/100人年(95%CI 2.93-5.17,I²=74%)。
- 未经调整的发病率比0.34(95%CI 0.26-0.46,I²=3%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The risk of recurrence after discontinuation of anticoagulation for a combined oral contraceptive (COC)-associated venous thromboembolism (VTE) is unclear. Therefore, we conducted a systematic review and meta-analysis to estimate the incidence of recurrent VTE among women with COC-associated VTE, unprovoked VTE and to compare the incidence of recurrent VTE between the two groups. The Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Embase Classic +Embase and Medline ALL to July 2020 and citations from included studies were searched. Randomized controlled trials, prospective cohort studies and meta-analyses of these study types were selected. The analysis was conducted by random-effects model. Nineteen studies were identified including 1537 women [5828 person-years (PY)] with COC-associated VTE and 1974 women (7798 PY) with unprovoked VTE. Studies were at low risk of bias. The incidence rate of VTE recurrence was 1.22/100 PY [95% confidence interval (CI) 0.92-1.62, I2 = 6%] in women with COC-associated VTE, 3.89/100 PY (95% CI 2.93-5.17, I2 = 74%) in women with unprovoked VTE and the unadjusted incidence rate ratio was 0.34 (95% CI 0.26-0.46, I2 = 3%). The recurrence risk in women after COC-associated VTE is low and lower than after an unprovoked VTE.
引用
- Abdulrehman J, Elbaz C, Aziz D, et al. Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis. Br J Haematol. 2022. PMID: 35877546. doi:10.1111/bjh.18331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。